CN101843644A - Chinese medicament for treating tachycardia - Google Patents

Chinese medicament for treating tachycardia Download PDF

Info

Publication number
CN101843644A
CN101843644A CN200910235489A CN200910235489A CN101843644A CN 101843644 A CN101843644 A CN 101843644A CN 200910235489 A CN200910235489 A CN 200910235489A CN 200910235489 A CN200910235489 A CN 200910235489A CN 101843644 A CN101843644 A CN 101843644A
Authority
CN
China
Prior art keywords
chinese medicine
chinese medicament
fine powder
chinese
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910235489A
Other languages
Chinese (zh)
Other versions
CN101843644B (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN200910235489XA priority Critical patent/CN101843644B/en
Publication of CN101843644A publication Critical patent/CN101843644A/en
Application granted granted Critical
Publication of CN101843644B publication Critical patent/CN101843644B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicament for treating tachycardia, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: borneol, radix pseudo-ginseng, lucid ganoderma, Szechuan lovage rhizome and benzoin. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, opening orifices and freeing spirit, and activating blood and dissolving stasis, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

The tachycardic Chinese medicine of a kind of treatment
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended at present treat the tachycardic field of Chinese medicines, come with some shortcomings: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many tachycardic middle-aged and elderly people are had palpitation for a long time, the torment of cardiopalmus, uncomfortable in chest, tachycardia, had a strong impact on quality of life, patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides the tachycardic Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the tachycardic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Borneolum Syntheticum 0.1-1.2 part Radix Notoginseng 3-20 part Ganoderma 2-12 part
Rhizoma Chuanxiong 4-30 part Benzoinum 4-30 part
The tachycardic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Chuanxiong, Benzoinum are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Borneolum Syntheticum, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma benefiting QI and nourishing blood in the side, tranquilizing by nourishing the heart has the body resistance strengthening and constitution consolidating, regulates the effect of immunity of organisms; Be aided with Rhizoma Chuanxiong, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Assistant is had one's ideas straightened out refreshing clearly with Borneolum Syntheticum, Benzoinum, the promoting flow of QI and blood pain relieving.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and it is refreshing clearly to have one's ideas straightened out, and the merit of blood circulation promoting and blood stasis dispelling is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Borneolum Syntheticum 1 gram Radix Notoginseng 50 kairine sesames 30 grams
Rhizoma Chuanxiong 60 gram Benzoinumes 60 grams
Weight in accordance with regulations, with conventional water extraction process Rhizoma Chuanxiong, Benzoinum are extracted, make extractum fine powder 36 grams, Borneolum Syntheticum, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 417 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Borneolum Syntheticum 6 gram Radix Notoginseng 100 kairine sesames 60 grams
Rhizoma Chuanxiong 150 gram Benzoinumes 150 grams
By above-mentioned same method, make 914 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Borneolum Syntheticum 12 gram Radix Notoginseng 200 kairine sesames 120 grams
Rhizoma Chuanxiong 300 gram Benzoinumes 300 grams
By above-mentioned same method, make 1828 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 5 portions of Ganodermas of 0.2 portion of Radix Notoginseng of Borneolum Syntheticum
7 parts of 7 parts of Benzoinumes of Rhizoma Chuanxiong
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
8 parts of 12 portions of Ganodermas of 0.8 portion of Radix Notoginseng of Borneolum Syntheticum
20 parts of 20 parts of Benzoinumes of Rhizoma Chuanxiong
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science tachycardia, through 8 routine clinical observations.Selecting tcm diagnosis cardiopalmus, tachycardia is standard: pulse is too fast during outbreak, nervous mental confusion, and feeling of distension and oppression over the chest, extremity are numb, and limb is soft weak, heart rate about 160 times/minute.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 3 examples do not have other serious disease, and the age is 41 years old-80 years old, 64.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, extremity energetically, cardiac distresses such as nervous cardiopalmus are obviously alleviated or are disappeared, cardiac distress, heart rate is below 100 times/minute.
2, effective: body constitution strengthens, and cardiac distresses such as nervous cardiopalmus are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.

Claims (1)

1. the tachycardic Chinese medicine of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Borneolum Syntheticum 0.1-1.2 part Radix Notoginseng 3-20 part Ganoderma 2-12 part
Rhizoma Chuanxiong 4-30 part Benzoinum 4-30 part
The tachycardic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Chuanxiong, Benzoinum are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Borneolum Syntheticum, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
CN200910235489XA 2009-10-16 2009-10-16 Chinese medicament for treating tachycardia Expired - Fee Related CN101843644B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910235489XA CN101843644B (en) 2009-10-16 2009-10-16 Chinese medicament for treating tachycardia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910235489XA CN101843644B (en) 2009-10-16 2009-10-16 Chinese medicament for treating tachycardia

Publications (2)

Publication Number Publication Date
CN101843644A true CN101843644A (en) 2010-09-29
CN101843644B CN101843644B (en) 2011-06-29

Family

ID=42768579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910235489XA Expired - Fee Related CN101843644B (en) 2009-10-16 2009-10-16 Chinese medicament for treating tachycardia

Country Status (1)

Country Link
CN (1) CN101843644B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103229881A (en) * 2013-05-10 2013-08-07 北京绿源求证科技发展有限责任公司 Heart nourishing food health-care tea electuary

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100540027C (en) * 2006-07-01 2009-09-16 邓德刚 The Chinese medicine preparation of treatment tachycardia and complication thereof
CN101168042A (en) * 2007-11-07 2008-04-30 周鲁菲 Traditional Chinese medicine preparation for curing cardiovascular and cerebrovascular diseases and preparing method
CN101554470A (en) * 2008-04-09 2009-10-14 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating tachycardia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103229881A (en) * 2013-05-10 2013-08-07 北京绿源求证科技发展有限责任公司 Heart nourishing food health-care tea electuary

Also Published As

Publication number Publication date
CN101843644B (en) 2011-06-29

Similar Documents

Publication Publication Date Title
CN101843661B (en) Chinese medicament for treating angina
CN101554470A (en) Traditional Chinese medicine for treating tachycardia
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843712B (en) Chinese medicament for treating angina
CN101843644B (en) Chinese medicament for treating tachycardia
CN101843753B (en) Chinese medicament for treating angina
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843755A (en) Chinese medicament for treating diabetic cardiopathy
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843645B (en) Chinese medicament for treating tachycardia
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843647B (en) Chinese medicament for treating angina
CN101843758B (en) Chinese medicament for treating coronary disease
CN101843720B (en) Chinese medicament for treating angina
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843700A (en) Chinese medicament for treating coronary disease
CN101850034B (en) Chinese medicament for treating angina
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843832B (en) Chinese medicament for treating coronary disease
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101843646A (en) Chinese medicament for treating tachycardia
CN101843698A (en) Chinese medicament for treating cervical spondylosis
CN101843792A (en) Chinese medicament for treating angina
CN101843730A (en) Chinese medicament for treating coronary disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166.

Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110629

Termination date: 20151016

EXPY Termination of patent right or utility model